(19)
(11) EP 1 227 810 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
16.08.2006 Bulletin 2006/33

(45) Mention of the grant of the patent:
21.06.2006 Bulletin 2006/25

(21) Application number: 00978553.6

(22) Date of filing: 13.11.2000
(51) International Patent Classification (IPC): 
A61K 31/365(2006.01)
A61K 45/06(2006.01)
A61P 35/00(2006.01)
A61K 31/341(2006.01)
C12Q 1/48(2006.01)
(86) International application number:
PCT/US2000/031067
(87) International publication number:
WO 2001/034145 (17.05.2001 Gazette 2001/20)

(54)

TREATING CANCER BY INCREASING INTRACELLULAR MALONYL COA LEVELS

BEHANDLUNG VON KREBS DURCH ERHÖHUNG DES MALONYL-COA-SPIEGELS

TRAITEMENT DU CANCER PAR AUGMENTATION DES TAUX DE MALONYL COA INTRACELLULAIRE


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 12.11.1999 US 164768 P
12.11.1999 US 164765 P

(43) Date of publication of application:
07.08.2002 Bulletin 2002/32

(60) Divisional application:
06012623.2

(73) Proprietor: THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Baltimore, MD 21202 (US)

(72) Inventors:
  • PIZER, Ellen, S.
    Columbia, MD 21029 (US)
  • TOWNSEND, Craig, A.
    Baltimore, MD 21212 (US)
  • KUHAJDA, Francis, P.
    Lutherville, MD 21209 (US)

(74) Representative: Dean, John Paul et al
Withers & Rogers LLP Goldings House, 2 Hays Lane
London SE1 2HW
London SE1 2HW (GB)


(56) References cited: : 
US-A- 5 539 132
US-A- 5 759 837
   
  • PIZER ELLEN S ET AL: "Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells." CANCER RESEARCH, vol. 56, no. 12, 1996, pages 2745-2747, XP000942097 ISSN: 0008-5472
  • KUHAJDA, F. P. (1) ET AL: "Synthesis and anti- tumor activity of a novel inhibitor of fatty acid synthase." PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, (MARCH, 1999) VOL. 40, PP. 121. MEETING INFO.: 90TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH PHILADELPHIA, PENNSYLVANIA, USA APRIL 10-14, 1999 AMERICAN , XP000942098
  • PIZER E S ET AL: "Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells." CANCER RESEARCH, (1996 FEB 15) 56 (4) 745-51. , XP000942096
  • PAUMEN MICHAEL B ET AL: "Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis." JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 6, 1997, pages 3324-3329, XP000942110 ISSN: 0021-9258 cited in the application
  • HENNIGAR RANDOLPH A ET AL: "Characterization of fatty acid synthase in cell lines derived from experimental mammary tumors." BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1392, no. 1, 20 May 1998 (1998-05-20), pages 85-100, XP000942091 ISSN: 0006-3002
  • PIZER ELLEN S ET AL: "Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty acid synthase inhibition in human breast cancer cell and xenografts." CANCER RESEARCH, vol. 60, 15 January 2000 (2000-01-15), pages 213-218, XP000983309 ISSN: 0197-016X
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).